Recent Press Releases

Students with Type 1 Diabetes Get a Boost from Lilly Diabetes to Attend College

Lilly Diabetes supports scholarships through donation to Diabetes Scholars Foundation

ROLLING MEADOWS, Ill. and

Valeant Pharmaceuticals Announces Expiration Of Bid Deadline In Connection With Agreement To Acquire Assets From Dendreon

02/10/2015 LAVAL, Quebec, Feb. 10, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that they have been advised by Dendreon Corporation that...

Leading US Companies Announce Major Healthcare Investment in London

LONDON, February 9, 2015 /PRNewswire/ -- London's status as a leading centre for the life sciences, financial and digital industries has attracted significant new investment by two leading US...

Pfenex And Hospira Announce Collaboration To Develop And Commercialize Proposed LUCENTIS® Biosimilar

SAN DIEGO and LAKE FOREST, Ill., Feb. 10, 2015 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira,...

Zydus Cadila Net Profit up by 52% in Q3

For the third quarter ended 31st December 2014, Cadila Healthcare Limited registered a Net Profit of Rs. 282 crores, up by 52% from Rs. 186 crores in the corresponding period last year. The company...

Roche acquires Signature Diagnostics to advance translational research for next generation sequencing (NGS) diagnostics

Roche will leverage Signature's unique expertise in both biobanks and NGS assays to develop novel diagnostics for cancer patients

PLEASAN

FDA approves Roche's Lucentis (ranibizumab injection) for treatment of diabetic retinopathy in people with diabetic macular edema

FDA approves Roche's Lucentis (ranibizumab injection) for treatment of diabetic retinopathy in people with diabetic macular edema First eye medicine approved for treatment of diabetic...

Novo Nordisk A/S seeks an initial public offering of NNIT

Bagsværd, Denmark, 9 February 2015 - Novo Nordisk A/S today announced the decision to seek an Initial Public Offering (IPO) of NNIT A/S on NASDAQ OMX Copenhagen A/S (Nasdaq Copenhagen). NNIT is...

HOSPIRA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Hospira, Inc. Board of Directors in Connection to the Proposed Sale of the Company to Pfizer, Inc. - HSP

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Hospira, Inc.

HOSPIRA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Hospira, Inc. Board of Directors in Connection to the Proposed Sale of the Company to Pfizer, Inc. - HSP

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Hospira, Inc.

Lilly to Present at Leerink Global Healthcare Conference

INDIANAPOLIS, Feb.

Pew, Other Groups Identify Potential Measures to Address Drug Shortages

Pew and other health care organizations released a report on February 5, 2015 exploring measures that should be considered to address the ongoing issue of drug shortages in the United States, which...

Merck Kicks off its Capacity Advancement Program - CAP in Collaboration with Emirates Diabetes Society- EDS for the first time in United Arab Emirates

Merck Kicks off its Capacity Advancement Program - CAP in Collaboration with Emirates Diabetes Society- EDS for the first time in United Arab Emirates The 5 year program was kicked off successfully...

Teva Thanks Dr. Phillip Frost for Board Service

JERUSALEM, Feb 05, 2015 (BUSINESS WIRE) -- The Board of Directors of Teva Pharmaceutical Industries Ltd. TEVA, +2.09% announced today that Dr. Phillip Frost has resigned from the Company's Board...

AstraZeneca to acquire rights to Actavis' branded respiratory portfolio in the US and Canada

Thursday, 5 February 2015 Agreement strengthens AstraZeneca's aclidinium respiratory franchise and adds immediate revenues with long-term growth potential AstraZeneca and Actavis Plc...